These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8092189)
41. [The molecular genetics of cystic fibrosis: the delta F508 allele in Mexican families]. Rojas-Martínez A; Vázquez-Alemán RM; Gustincich S; Cantú JM; Barrera-Saldaña HA Bol Med Hosp Infant Mex; 1992 Jun; 49(6):335-41. PubMed ID: 1632907 [TBL] [Abstract][Full Text] [Related]
42. Molecular basis of human complement C1s deficiency. Endo Y; Kanno K; Takahashi M; Yamaguchi Ki; Kohno Y; Fujita T J Immunol; 1999 Feb; 162(4):2180-3. PubMed ID: 9973493 [TBL] [Abstract][Full Text] [Related]
43. Assessment of the reliability of single blastomere analysis for preimplantation diagnosis of the delta F508 deletion causing cystic fibrosis in clinical practice. Ray PF; Ao A; Taylor DM; Winston RM; Handyside AH Prenat Diagn; 1998 Dec; 18(13):1402-12. PubMed ID: 9949440 [TBL] [Abstract][Full Text] [Related]
44. Cost-effective one-step PCR amplification of cystic fibrosis delta F508 fragment in a single cell for preimplantation genetic diagnosis. Tsai YH Prenat Diagn; 1999 Nov; 19(11):1048-51. PubMed ID: 10589057 [TBL] [Abstract][Full Text] [Related]
45. Delta F508 testing of the DNA bank of the Royal Manchester Children's Hospital. Schwarz MJ; Super M; Wallis C; Beighton P; Newton C; Heptinstall LE; Summers C; Markham A; Hambleton G; Webb KW Hum Genet; 1990 Sep; 85(4):428-30. PubMed ID: 2210763 [TBL] [Abstract][Full Text] [Related]
47. [Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis]. Repetto G; Poggi H; Harris P; Navarro H; Sánchez I; Guiraldes E; Pérez MA; Boza ML; Hunter B; Wevar ME; Mediavilla M; Foradori A Rev Med Chil; 2001 Aug; 129(8):841-7. PubMed ID: 11680956 [TBL] [Abstract][Full Text] [Related]
48. Use of PCR for the determination of the frequency of the delta F508 mutation in Brazilian cystic fibrosis patients. de Miranda AB; Llerena Júnior J; Dallalana LT; Moura-Neto RS; Suffys PN; Degrave WM Mem Inst Oswaldo Cruz; 1993; 88(2):309-12. PubMed ID: 8107592 [TBL] [Abstract][Full Text] [Related]
49. Severity of chest disease in cystic fibrosis patients in relation to their genotypes. al-Jader LN; Meredith AL; Ryley HC; Cheadle JP; Maguire S; Owen G; Goodchild MC; Harper PS J Med Genet; 1992 Dec; 29(12):883-7. PubMed ID: 1479603 [TBL] [Abstract][Full Text] [Related]
50. Clinical features of cystic fibrosis patients with rare genotypes in Saguenay Lac-Saint-Jean (Quebec, Canada). de Braekeleer M; Mari G; Verlingue C; Allard C; Leblanc JP; Simard F; Aubin G; Férec C Ann Genet; 1997; 40(4):205-8. PubMed ID: 9526613 [TBL] [Abstract][Full Text] [Related]
51. Cystic Fibrosis in Ukraine: age, origin and tracing of the delta F508 mutation. Livshits LA; Kravchenko SA Gene Geogr; 1996 Dec; 10(3):219-27. PubMed ID: 9263776 [TBL] [Abstract][Full Text] [Related]
52. [Detection of Delta-F508 mutation by PCR (polymerase chain reaction) in patients with cystic fibrosis]. Ferrer Calvete J; Cordoba J; Beneyto M; Ribes C; Pereda A An Esp Pediatr; 1993 Dec; 39(6):557-8. PubMed ID: 8166420 [No Abstract] [Full Text] [Related]
53. Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population. Casals T; Gimenez J; Ramos MD; Nunes V; Estivill X Prenat Diagn; 1996 Mar; 16(3):215-22. PubMed ID: 8710774 [TBL] [Abstract][Full Text] [Related]
54. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation. Keller BM; Aebischer CC; Kraemer R; Schöni MH J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854 [TBL] [Abstract][Full Text] [Related]
55. Identification of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency in four Italian families. Oppliger T; Thöny B; Kluge C; Matasovic A; Heizmann CW; Ponzone A; Spada M; Blau N Hum Mutat; 1997; 10(1):25-35. PubMed ID: 9222757 [TBL] [Abstract][Full Text] [Related]
56. [Polymerase chain reaction in analysis of deletion F-508 in cystic fibrosis]. Voronina OV; Gaĭtskhoki VS; Shvarts EI; Potapova OIu; Berlin IuA; Plutalov OV; Gembitskaia TE Bioorg Khim; 1990 Oct; 16(10):1430-1. PubMed ID: 2085328 [No Abstract] [Full Text] [Related]
57. Applications of the polymerase chain reaction (PCR) in diagnosis. Fanning S; Joyce C; Corbett A; O'Mullane J; Cryan B Ir J Med Sci; 1995; 164(2):116-21. PubMed ID: 7607835 [TBL] [Abstract][Full Text] [Related]
58. Association of less common cystic fibrosis mutations with a mild phenotype. Curtis A; Nelson R; Porteous M; Burn J; Bhattacharya SS J Med Genet; 1991 Jan; 28(1):34-7. PubMed ID: 1999830 [TBL] [Abstract][Full Text] [Related]
59. Identification of a cystic fibrosis mutation: deletion of isoleucine506. Nelson PV; Carey WF; Morris CP Hum Genet; 1991 Feb; 86(4):391-3. PubMed ID: 1999342 [TBL] [Abstract][Full Text] [Related]
60. Haplotype analysis of the CFTR gene region and the proportion of delta F508 deletion in Slovak patients with cystic fibrosis. Kádasi L; Gécz J; Krivusová T; Matúsek J; Ferák V Funct Dev Morphol; 1992; 2(2):141-2. PubMed ID: 1450460 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]